Skip to content
2000
Volume 6, Issue 3
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Selective inhibition of COX-2 provided a new class of anti-inflammatory, analgesic and antipyretic drugs with significantly reduced side effects and could also be an important strategy for preventing or treating a number of cancers. This review illustrates the molecular modeling methods used for the knowledge of the molecular mechanism of inhibition as well as for the design of selective compounds.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/187152006776930909
2006-05-01
2025-05-07
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/187152006776930909
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test